Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera

Por Gisslinger, Heinz, Zagrijtschuk, Oleh, Buxhofer-Ausch, Veronika, Thaler, Josef, Schloegl, Ernst, Gastl, Guenther A., Wolf, Dominik, Kralovics, Robert, Gisslinger, Bettina, Strecker, Karin, Egle, Alexander, Melchardt, Thomas, Burgstaller, Sonja, Willenbacher, Ella, Schalling, Martin, Them, Nicole C., Kadlecova, Pavla, Klade, Christoph, Greil, Richard
Publicado no Blood (2015)

Changes induces by haloperidol (antidepressant drug) on the developing retina of the chick embryo

Por Abd-Elmagid, Badria Fathy, Al-Ghamdi, Fawzyah Abdullah
Publicado em 2009

Choice of Starting Dose for Biopharmaceuticals in First-in-Human Phase I Cancer Clinical Trials

Por Hansen, Aaron R., Cook, Natalie, Ricci, M. Stacey, Razak, Albiruni, Le Tourneau, Christophe, McKeever, Kathleen, Roskos, Lorin, Dixit, Rakesh, Siu, Lillian L., Hinrichs, Mary Jane
Publicado no Oncologist (2015)

Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all

Por Oei, Arlene L., Vriend, Lianne E. M., Crezee, Johannes, Franken, Nicolaas A. P., Krawczyk, Przemek M.
Publicado no Radiat Oncol (2015)

Drug delivery: enabling technology for drug discovery and development.iPRECIO® Micro Infusion Pump: Programmable, refillable and implantable

Por Tsung eTan, Stephanie W Watts, Robert Patrick Davis
Publicado em 2011-07-01

Development of a mobile application for vancomycin dosing calculation: A useful tool for the rational use of antimicrobials

Por Tácio de Mendonça Lima, Millena Padela da Silva, Luan Donato Silva Luz, Thais Cristina Amorim Estevão Soares, Etielle Silvestre Dantas, Gabriela Felix Teixeira, Rafael Henrique de Souza Costa, Sérgio Henrique Monte Santo Andrade
Publicado em 2022-03-01

Time-programmable drug dosing allows the manipulation, suppression and reversal of antibiotic drug resistance in vitro

Por Yoshida, Mari, Reyes, Sabrina Galiñanes, Tsuda, Soichiro, Horinouchi, Takaaki, Furusawa, Chikara, Cronin, Leroy
Publicado no Nat Commun (2017)

Potential of magnetic nanoparticles for targeted drug delivery

Por Yang, Hung-Wei, Hua, Mu-Yi, Liu, Hao-Li, Huang, Chiung-Yin, Wei, Kuo-Chen
Publicado em 2012

Myoclonus associated with treatment with high doses of morphine: the role of supplemental drugs.

Por Potter, J. M., Reid, D. B., Shaw, R. J., Hackett, P., Hickman, P. E.
Publicado em 1989

Ascidian Toxins with Potential for Drug Development

Por Watters, Dianne J.
Publicado no Mar Drugs (2018)

Availability and rationality of fixed dose combinations available in Kaduna, Nigeria

Por Fatima Auwal, Mohammed N. Dahiru, Samirah N. Abdu-Aguye
Publicado no Pharmacy Practice (2019)

Anticancer Alkaloids from Trees: Development into Drugs

Por Isah, Tasiu
Publicado no Pharmacogn Rev (2016)

Advancing Clinical Trials to Streamline Drug Development

Por Bates, Susan E., Berry, Donald A., Balasubramaniam, Sanjeeve, Bailey, Stuart, Rubin, Eric H., LoRusso, Patricia M.
Publicado no Clin Cancer Res (2015)

ANALYSIS OF CONSUMPTION OF ANTIBACTERIAL DRUGS FOR SYSTEMIC USE IN HOSPITALS OF SAINT PETERSBURG IN 2014–2015

Por Yu. M. Gomon, A. A. Kurylev, A. S. Kolbin, M. A. Proskurin, I. G. Ivanov, S. V. Sidorenko, M. A. Arepieva, A. V. Sokolov
Publicado em 2018-10-01

Clinical development of fenretinide as an antineoplastic drug: Pharmacology perspectives

Por Cooper, Jason P, Reynolds, C Patrick, Cho, Hwangeui, Kang, Min H
Publicado no Exp Biol Med (Maywood) (2017)

Combatting synthetic designer opioids: active vaccination ablates lethal doses of fentanyl class drugs

Por Bremer, Paul T., Kimishima, Atsushi, Schlosburg, Joel E., Zhou, Bin, Collins, Karen C., Janda, Kim D.
Publicado no Angew Chem Int Ed Engl (2016)

Drug development in oncology: classical cytotoxics and molecularly targeted agents

Por Kummar, Shivaani, Gutierrez, Martin, Doroshow, James H, Murgo, Anthony J
Publicado em 2006

Genetic Characterization of Second-Line Drug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis from the Northern Region of India

Por Rakesh Yadav, Aastha Saini, Jureka Mankotia, Rajiv Khaneja, Priyanka Agarwal, Sunil Sethi
Publicado em 2018-12-01

Maximizing the value of medicines by including pharmacogenetic research in drug development and surveillance

Por Brazell, C, Freeman, A, Mosteller, M
Publicado em 2002

Drug Delivery: Enabling Technology for Drug Discovery and Development. iPRECIO(®) Micro Infusion Pump: Programmable, Refillable, and Implantable

Por Tan, Tsung, Watts, Stephanie W., Davis, Robert Patrick
Publicado em 2011